This book was retrived from archive.org

DTIC ADA481528: Intravenous Artesunate: The New Generation pdf

DTIC ADA481528: Intravenous Artesunate: The New Generation_bookcover

DTIC ADA481528: Intravenous Artesunate: The New Generation

More Book Details

Description of the Book:

Artemisinins are antimalarials derived from the Chinese herb, Artemisia annua. These compounds clear the parasites from the blood more rapidly than other antimalarial agents. Intravenous formulations of artemisinins have been used in much of the world and represent an improvement in efficacy and safety for severe malaria. There are currently no FDA-approved intravenous artemisinin products available in the U.S. The Walter Reed Army Institute of Research has a long history with the artemisinins which has culminated in an intravenous artemisinin product. Between 2000 and 2002, two derivatives were in consideration (artesunate and artelinate) for development to licensure. After intense scrutiny and eventual consideration in committee at the Division of Experimental Therapeutics, artesunate was selected as the compound to put forward into advanced development. Artesunate is currently in use in much of the malarial world as a non- International Conference on Harmonisation (ICH) current Good Manufacturing Practices (cGMP) intravenous formulation produced in China and therefore gives us a potential wealth of clinical data.

We envision our formulation of an ICH compliant, cGMP-produced, and FDA-licensed intravenous artesunate being available for use in the very near future for US military and civilians as well as eventual use worldwide. We have successfully filed an Investigational New Drug Application for this product and clinical trials with this agent are well underway. Our presentation will update the progress that has been made in preclinical studies, data from early current Good Clinical Practices (cGCP) Phase 1 trials (the first regulated Phase 1 work ever done with artesunate), data from early cGCP Phase 2 trials in Kenya, future planned clinical work, and our overall strategy for gaining full licensure of this product in the United States by the end of 2007

  • Creator/s: Defense Technical Information Center
  • Date: 11/1/2006
  • Year: 2006
  • Book Topics/Themes: DTIC Archive, Weina, P J, WALTER REED ARMY INST OF RESEARCH SILVER SPRING MD, *ANTIMALARIALS, *CLINICAL TRIALS, INJECTIONS(MEDICINE), SYMPOSIA

An excerpt captured from the PDF book

DTIC ADA481528: Intravenous Artesunate: The New Generation_book-excerpt

Report Broken Link

File Copyright Claim

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Categories

You might be also interested in these Books

Related Posts
PDF Viewer

الرجاء الانتظار بينما يتم تحميل الـ PDF…
HTML Popup Example